Published on 06/16/2022 at 08:46
Photo credit © DBV
(Boursier.com) — DBV Technologies, a clinical-stage biopharmaceutical company, announced that Daniel Tassé, Chief Executive Officer, and Pharis Mohideen, Chief Medical Officer, will participate in a fireside chat this Thursday, June 16, 2022 at 12:00 p.m. ET at the JMP Securities Life Sciences conference in New York. A webcast of the presentation will be available in the Investors and Media section of the Company’s website. A replay of the presentation will also be available on the DBV website after the event.
–
©2022 Boursier.com
–
